Allergomed

Allergomed is a specialized pharmaceutical company focused on the development, production, and distribution of products for the diagnosis and treatment of allergic diseases. The company primarily offers allergen immunotherapy (AIT) solutions, including subcutaneous immunotherapy (SCIT) for respiratory and venom allergies. As a key entity within the Allergopharma group, Allergomed provides a range of high-dosage, standardized allergen preparations designed to modify the underlying cause of allergic reactions. Following its acquisition by Dermapharm in 2020, the company continues to serve the European market with a focus on precision diagnostics and long-term allergy management.